- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Banking and Institutional Finance
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations
- Private Equity
- Public Companies
- Real Estate
- Structured Finance and Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy
- Financial Services
- Food and Beverage
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- Buy American
- COVID-19 Vaccine Rollout
- Crisis Management
- Environmental Agenda
- Environmental, Social and Governance (ESG)
- Focus on Women's Health
- Russia/Ukraine
- Special Purpose Acquisition Companies (SPACs)
- Careers
- News & Insights
- About
- Languages
John C. Richter
News 15 results
In the News · Source: The New York Times
April 8, 2022
Tom Spulak, John Richter and William McClintock represent a steel producer in a Federal Election Commission enforcement action
In the News · Source: Bloomberg Law
Recognition
November 10, 2021
GIR Names King & Spalding to List of Top 30 Global Investigations Firms for Seventh Year
Recognition
October 13, 2021
Benchmark Litigation Recognizes King & Spalding as a Leading Litigation Firm
Events 14 results
Webinar
November 9, 2021
King & Spalding Pharmaceutical University 2021
Webinar
November 10, 2020
13th Annual King & Spalding Medical Device Summit
Conference
November 12, 2019
12th Annual King & Spalding Pharmaceutical University
Speaking Engagement
November 6, 2019
John Richter, Richard Walker, Nikki Reeves to Speak at 20th Annual Pharmaceutical and Medical Device Compliance Congress
Insights 27 results
Client Alert
May 16, 2022
Cooperation Credit and Attorney-Client Privilege: The Implications of Coburn
Article
October 27, 2021
Congress Can Do Better Against Fraud
Article · Source: U.S. Chamber of Commerce Litigation Center Blog
August 12, 2021
Top False Claims Act Developments
Feature
February 10, 2021
General Counsel Internal Investigations Decision Tree for the Automotive Industry